Biomedicine & Pharmacotherapy
Publisher: Elsevier · ISSN 0753-3322 · 92 articles
- Estrogen receptor modulation by a newly-identified cannabinoid in a preclinical model of breast cancer
- Identification of TAS2R-targeting bioactive compounds against metabolic decline: A novel ex vivo methodology based on enteroendocrine and inflammatory readouts
- Pharmacokinetic investigation of TRPA1 receptor antagonists: A967079 and HC-030031 in mouse model
- Mechanistic insights into cholesterol-mediated MASH pathogenesis: Glycation, lipoxidation, and RAGE pathway
- Lipid-based nanoencapsulation prolongs the antinociceptive effect of cannabidiol in experimental neuropathic pain
- DHA-H and HPA restore impaired neurogenic phenotypes and BDNF-TrkB signaling in Ts65Dn neurospheres and hippocampus
- Photothermally amplified NO release from arginine-encapsulated injectable nanocomposite hydrogel for triple-synergistic antitumor therapy
- Natural circular peptides regulate T-lymphocyte proliferation by inhibiting prolyl oligopeptidase
- Urinary tract and genital infections with dapagliflozin and empagliflozin across type 2 diabetes, heart failure, and chronic kidney disease: An indication- and sex-stratified disproportionality analysis of eudravigilance reports
- Melatonin-loaded proniosomes enhance gemcitabine response in gemcitabine-resistant cholangiocarcinoma: Proteomic and computational insights
- Association of GLP-1 receptor agonist therapy with cardiovascular outcomes in patients with MASLD: A translational study
- FTO mediated glycolytic metabolism for papillary renal cell carcinoma immune evasion
- Withaferin A induces a decrease in sacsin levels and the collapse of nestin networks: Relevance for glioblastoma
- Metabolic-translational control of NK cell fitness under chronic stress
- The Plasminogen Activator Inhibitor 1 (PAI-1) paradox in cancer: From tumor microenvironment remodeling to therapeutic targeting
- α-pinene and the central nervous system: Mechanistic insights, preclinical evidence, and translational perspectives
- Extracellular vesicles in viral myocarditis: Mechanisms, biomarkers and emerging therapeutic strategies
- Combining brain-penetrating and anticancer peptides into bivalent-branched peptides conserves brain targeting and improves activity in vitro
- Pharmacokinetics and target attainment of aztreonam/avibactam in plasma and tissue: A human microdialysis study
- Propranolol disrupts fear-induced persistent cocaine place preference and unmasks an aversion component
- Vasodilatory and antihypertensive effects of sotagliflozin: Ex vivo evaluation in isolated rat aortic rings and an in vivo assessment in spontaneously hypertensive rats
- Formononetin disrupts MRSA biofilm via potential SarA-associated regulatory modulation
- Fourth-generation multi-costimulatory chimeric antigen receptor T cells targeting CD133 and integrin αvβ6 exert potent antitumor activity in cholangiocarcinoma
- Early-stage inhibition of HIV-1 subtypes A, B, and C gag- protease chimeras by Penicillium chrysogenum P03MB2 metabolites and activity against cell-to-cell spread
- The IgM- and IgA-enriched immunoglobulin preparation trimodulin suppresses neutrophil extracellular trap formation more effectively in vitro than standard intravenous immunoglobulin
- Elastin-based polypeptide–Fc fusion for extended subcutaneous exposure and sustained thrombopoietic activity
- Lactiplantibacillus plantarum alleviates Parkinson’s disease progression by reducing enteroendocrine α-synuclein aggregation in a rotenone-induced mouse model
- Formulation-controlled redaporfin cellular-targeted photodynamic therapy sensitizes tumors to PD-1/PD-L1 blockade via immunogenic cell death
- Contribution of angiotensin receptor type II to dermal extravasation caused by bradykinin in mice: Implications for sartan-induced angioedema
- Juglone exerts acaricidal activity against Sarcoptes scabiei via dual inhibition of mite mitochondrial complexes III and IV for scabies control